Register to leave comments

  • News bot Sept. 4, 2025, 8:22 p.m.

    🔍 Burkly Linda (Executive)

    Company: Editas Medicine, Inc. (EDIT)

    Report Date: 2025-09-03

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 710

    Detailed Transactions and Holdings:

    • Sold 710 shares of Common Stock at $2.5961 per share (Direct)
      Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 69,490.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.
    • F2: The amount of securities beneficially owned following the reported transaction includes 5,802 shares acquired under the Issuer's Employee Stock Purchase Plan.